Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption
Aims: Bone destruction is a pivotal pathological factor in the development of joint disability in rheumatoid arthritis (RA) patients, and there is a paucity of safe and effective drugs targeting bone destruction. Xuetong (Kadsura heteroclita Roxb), a traditional Tujia medicine with blood-activating...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The British Editorial Society of Bone & Joint Surgery
2025-11-01
|
| Serier: | Bone & Joint Research |
| Fag: | |
| Online adgang: | https://online.boneandjoint.org.uk/doi/epdf/10.1302/2046-3758.1411.BJR-2025-0259.R1 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
